[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 13, 1967

Evaluation of Renal Transplant Function by Iodohippurate Sodium I 131

Author Affiliations

From the Harvard Medical School (Drs. Merrill and Blaufox); the Department of Medicine (Dr. Blaufox) and the Cardiorenal Section (Dr. Merrill), Peter Bent Brigham Hospital, Boston; and the Howard Hughes Institute, Miami Beach, Fla (Dr. Merrill). Dr. Blaufox was an advanced research fellow of the American Heart Association. He is now with the Albert Einstein College of Medicine, New York, and was a research fellow in medicine at the Harvard Medical School.

JAMA. 1967;202(7):575-578. doi:10.1001/jama.1967.03130200061009

Iodohippurate sodium I 131 clearances were used to evaluate renal function in 15 patients after transplantation. The iodohippurate clearance was found to be of prognostic value if performed during the first day after transplantation. In addition, it was helpful in evaluating renal function and detecting renal transplant rejection, especially during the first four weeks following surgery.